Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement: Love SC et al.


European Journal of Neurology  2010,  17  (Suppl. 2): 9–3


S. C. Love  a,
I. Novak  b,
M. Kentish  c,
K. Desloovere  d.
F. Heinen  e,
G. Molenaers  f,
S. O. Flaherty  g
and H. K. Graham  h


Author Details
a  Centre for Musculoskeletal Studies, University of Western Australia, Princess Margaret Hospital, Western Australia;
b  Cerebral Palsy Institute, School of Medicine, University of Notre Dame Australia, Darlinghurst, Sydney, NSW;
c  Queensland Cerebral Palsy Health Service, Department of Paediatric Rehabilitation, Royal Children‘s Hospital, Brisbane, QLD, Australia;
d  Department of Rehabilitation Sciences, KUL, Leuven, Belgium;
e  Paediatric Neurology & Developmental Medicine, Children’s Hospital University of Munich, Munich, Germany;
f   Department of Musculoskeletal Sciences, KUL, Leuven, Belgium;
g  Rehabilitation Dept, Children‘s Hospital at Westmead, Westmead, NSW, Australia; and 
h  University of Melbourne, Department of Orthopaedics and Murdoch Children‘s Research Institute, The Royal Children‘s Hospital, Parkville, Vic., Australia